#67 Notable Clinical Interest
Emerging findings or policy developments worth monitoring closely.
Clinicians should understand that the endocannabinoid system, particularly anandamide, contributes to exercise-induced mood improvements and pain relief independent of endorphins, which has implications for patients seeking non-pharmacological interventions for anxiety and chronic pain. This knowledge helps providers counsel patients on the neurobiological mechanisms of physical activity and may inform discussions about whether cannabis-derived cannabinoids could offer similar therapeutic pathways for patients unable to exercise. Recognition that endocannabinoids modulate anxiety and pain through distinct mechanisms from traditional pain pathways could guide clinicians in selecting appropriate treatments and setting realistic expectations for cannabis efficacy in their patient populations.
This article discusses anandamide, the endogenous cannabinoid that contributes to the “runner’s high” phenomenon, highlighting its anxiolytic, analgesic, and mood-enhancing properties and its superior ability to cross the blood-brain barrier compared to endorphins. The piece underscores the endocannabinoid system’s natural role in producing therapeutic effects including anxiety reduction, pain relief, and psychological wellbeing. For clinicians, understanding that patients may seek cannabis to replicate or enhance these naturally occurring endocannabinoid responses provides context for why certain patients are drawn to cannabinoid therapies, particularly those with anxiety, chronic pain, or mood disorders. This neurobiological framework can inform patient discussions about the endogenous cannabinoid system and how exogenous cannabinoids interact with pathways that the body already uses for stress regulation and pain management. Clinicians should recognize that some patients’ cannabis use may represent an attempt to modulate their endocannabinoid tone in ways their own physiology may not adequately provide, which can guide more empathetic and evidence-based counseling.
“The neurochemistry of exercise is genuinely fascinating, and anandamide’s role in the runner’s high is an area where we’re seeing consistent mechanistic interest, but I’d emphasize that most of what we know here comes from animal models and indirect human evidence rather than direct measurement studies. That said, understanding how endogenous cannabinoid signaling contributes to exercise-induced mood benefits is exactly the kind of foundational work that could eventually inform how we think about movement as medicine.”
🏃 The neurochemistry underlying exercise-induced euphoria involves multiple endogenous compounds beyond endorphins, including anandamide and other endocannabinoids that may contribute to anxiety reduction and analgesia. While this mechanistic understanding is scientifically interesting, clinicians should recognize that patient expectations about cannabis use may be influenced by popular characterizations of “runner’s high,” potentially leading some to self-medicate with exogenous cannabinoids rather than pursuing physical activity for mental health benefits. It is important to acknowledge that endogenous endocannabinoid signaling during exercise differs substantially from exogenous cannabis administration in terms of dose, timing, and systemic effects, and that cannabis carries its own risks including cognitive impairment, dependence, and psychiatric complications that exercise does not. When counseling patients about anxiety, pain, or mood, providers should emphasize evidence-based non-pharmacological approaches such as structured physical
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it:
